Table 1.
Characteristics of the study participants
| Parameter | Control (n=40) | T2DM with MS (n=50) | P |
|---|---|---|---|
| Age (year) | 54.24±511 | 55.44±7.03 | 0.406 |
| Weight (kg) | 76.09±12.38 | 84.54±13.04 | 0.003 |
| WC (cm) | 95.22±10.5 | 105.52±9.91 | 0.000 |
| HC (cm) | 99327±9.25 | 106.09±7.26 | 0.001 |
| WHR | 0.96±0.094 | 0.99±0.050 | 0.05 |
| BMI (kg/m2) | 22.69±3.43 | 24.85±0.3.54 | 0.007 |
| SBP (mmHg) | 123.16±14.44 | 130.75±13.44 | 0.015 |
| DBP (mmHg) | 79.45±9.74 | 79.65±1715 | 0.947 |
| FBG (mg/dL) | 96.66±10.62 | 157.02±42.05 | 0.000 |
| A1c (%) | 5.46±0.41 | 7.50+±1.59 | 0.000 |
| HOMA-IR | 2.67±1.30 | 5.46±3.74 | 0.000 |
| TC (mg/dL) | 192.16±30.37 | 193.18±44.92 | 0.904 |
| TG (mg/dL) | 126.19±31.16 | 203.82±85.29 | 0.000 |
| HDL-C (mg/dL) | 46.37±5.71 | 35.96±6.19 | 0.000 |
| LDL-C (mg/dL) | 117.5±24.57 | 114.57±33.61 | 0.653 |
| FINS (U/L) | 11.3±5.18 | 13.79±6.69 | 0.04 |
| Hs-CRP (mg/L) | 1.77±1.89 | 2.12±1.54 | 0.366 |
Data are expressed as mean±SD. Significant P values are shown in bold. BMI=Body mass index; DBP=Diastolic blood pressure; FBG=Fasting blood glucose; FINS=Fasting insulin; HbA1c=Hemoglobin A1c; HC=Hip circumference; HDL-C=High-density lipoprotein-cholesterol; HOMA-IR=Homeostasis Model Assessment of Insulin Resistance; hs-CRP=High-sensitivity C-reactive protein; LDL-C=Low-density lipoprotein-cholesterol; SBP=Systolic blood pressure; TC=Total cholesterol; TG=Triglyceride; WC=Waist circumference; WHR=Waist-hip ratio; SD=Standard deviation; T2DM=Type-2 diabetes mellitus; MS=Metabolic syndrome